Compare AIOT & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIOT | BNTC |
|---|---|---|
| Founded | 1993 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.6M | 454.2M |
| IPO Year | 2024 | 2020 |
| Metric | AIOT | BNTC |
|---|---|---|
| Price | $3.03 | $12.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $10.33 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 2.5M | 173.4K |
| Earning Date | 06-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.12 | ★ 80.94 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $443,777,000.00 | N/A |
| Revenue This Year | $24.46 | N/A |
| Revenue Next Year | $9.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.42 | N/A |
| 52 Week Low | $2.78 | $9.85 |
| 52 Week High | $5.88 | $16.76 |
| Indicator | AIOT | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 41.39 | 46.94 |
| Support Level | $3.01 | $11.36 |
| Resistance Level | $3.14 | $13.79 |
| Average True Range (ATR) | 0.13 | 0.85 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 61.29 | 29.88 |
PowerFleet Inc provides artificial intelligence of things (AIoT) software-as-a-service (SaaS) solutions for the mobile asset industry globally. The company's Unity data highway and AIoT ecosystem ingest data from multiple data sources and deliver actionable insights through a Software-as-a-Service (SaaS) platform, for improving the performance of the mobile asset (such as forklifts, tuggers, trucks, rental cars, etc.), the individual in charge, and the business process. Its offerings include a variety of IoT devices integrated with software solutions for asset tracking, operational monitoring, AI-powered video safety, compliance management, and analytics under brands such as Powerfleet, Pointer, Cellocator, MiX by Powerfleet, and Fleet Complete. The company's key market is North America.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.